Ginkgo Bioworks Inc. (DNA)
NYSE: DNA
· Real-Time Price · USD
12.30
-1.50 (-10.87%)
At close: Aug 19, 2025, 12:08 PM
Ginkgo Bioworks Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for DNA stock have an median target of 8.5, with a low estimate of 7 and a high estimate of 10. The median target predicts a decrease of -30.89% from the current stock price of 12.30.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 7 | 8.5 | 8.5 | 10 |
| Change | -43.09% | -30.89% | -30.89% | -18.70% |
Latest Analyst Insight Report
According to 2 stock analyst, the rating for Ginkgo Bioworks Inc. is "Hold". This means that the analyst believes this stock is likely to lead to similar returns than market as a whole.
| Rating | Aug 24 | Sep 24 |
|---|---|---|
| Strong Buy | 0 | 1 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 1 | 0 |
| Strong Sell | 0 | 0 |
| Total | 1 | 1 |
Financial Forecast this Year
Revenue This Year
177.39M
from 227.04M
Increased by -21.9%
Revenue Next Year
206.33M
from 177.39M
Increased by 16.3%
EPS This Year
-5.85
from -10.54
Increased by 44.5%
EPS Next Year
-4.78
from -5.85
Increased by 18.3%